These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9080863)

  • 1. Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
    Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):27-30. PubMed ID: 9080863
    [No Abstract]   [Full Text] [Related]  

  • 2. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction.
    Mannino MM; Mehta D; Langan NM; Gomes JA
    Am Heart J; 1996 Jun; 131(6):1251-9. PubMed ID: 8644621
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 5. [Implantable automatic defibrillator after MADIT and EMIAT].
    Farré J
    Rev Esp Cardiol; 1996 Oct; 49(10):709-13. PubMed ID: 9036472
    [No Abstract]   [Full Text] [Related]  

  • 6. Which device should "MADIT protocol" patients receive? Multicenter Automatic Defibrillator Implantation Trial.
    Higgins SL; Klein H; Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):31-5. PubMed ID: 9080864
    [No Abstract]   [Full Text] [Related]  

  • 7. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
    Block M; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Background, outcome, and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT).
    Moss AJ
    Am J Cardiol; 1997 Sep; 80(5B):28F-32F. PubMed ID: 9291447
    [No Abstract]   [Full Text] [Related]  

  • 9. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
    Coats AJ
    Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVID necessity.
    Epstein AE
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1773-5. PubMed ID: 7692406
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 14. Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial.
    Higgins SL; Daubert JL; Akhtar M
    Am J Cardiol; 1997 Sep; 80(5B):42F-46F. PubMed ID: 9291449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
    Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
    Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
    [No Abstract]   [Full Text] [Related]  

  • 16. What can we expect from prophylactic implantable defibrillators?
    Wilber DJ; Kall JG; Kopp DE
    Am J Cardiol; 1997 Sep; 80(5B):20F-27F. PubMed ID: 9291446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.
    Reynolds MR; Josephson ME
    Circulation; 2003 Oct; 108(15):1779-83. PubMed ID: 14557341
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
    Prystowsky EN; Nisam S
    Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is prophylaxis the best use of the ICD? Response to the letter to the editor (Sharma et al.).
    Farré J; Nisam S
    Eur Heart J; 2003 May; 24(9):880-1. PubMed ID: 12727158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.